Monitise says trading remains strong

Monitise, the AIM-listed mobile banking and payments group, told investors at its annual general meeting that trading remains strong and in line with expectations, following continued momentum in the business during the first quarter.

Monitise, the AIM-listed mobile banking and payments group, told investors at its annual general meeting that trading remains strong and in line with expectations, following continued momentum in the business during the first quarter.

The firm told how it is "delighted" with the integration of Clairmail and said the Monitise Americas business continues to perform well.

More than 17m registered customers globally currently have access to the services delivered by its Monitise Enterprise Platform.

In its annual results released in September, the company said revenues in the 12 months ended June 30th jumped from £15.3m to £36.1m, an increase of 136%. Development and integration revenues, which fuel future user generated revenues, surged by 237% from just £7.0m to £23.6m. User generated revenues increased by 69% from £7.4m to £12.5m.

On Thursday the share price 0.67% to 37.50p by 12:38.

NR

Recommended

Share tips of the week – 19 August
Share tips

Share tips of the week – 19 August

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
19 Aug 2022
How to invest in smart factories as the “fourth industrial revolution” arrives
Share tips

How to invest in smart factories as the “fourth industrial revolution” arrives

Exciting new technologies and trends are coming together to change the face of manufacturing. Matthew Partridge looks at the companies that will drive…
18 Aug 2022
How to invest today? Look to the past, not the future
Investment strategy

How to invest today? Look to the past, not the future

The past few years have seen so many changes to our way of life that many people said we had entered a “new normal”. But as it turns out, the new norm…
18 Aug 2022
A new legal headache for Haleon
Stocks and shares

A new legal headache for Haleon

Haleon, GSK’s former consumer-products arm, spun off last month, has made a dismal debut on the stockmarket.
17 Aug 2022

Most Popular

How to protect your wealth as inflation hits new record highs
Investment strategy

How to protect your wealth as inflation hits new record highs

UK inflation has hit a new record high of 10.1%. It's going to hurt, says Dominic Frisby. Here's how you can protect your wealth.
17 Aug 2022
How to cut your energy bill
Personal finance

How to cut your energy bill

The energy-price cap will almost double in the autumn. What does this mean for your money, and how can you alleviate the squeeze? Ruth Jackson-Kirby h…
17 Aug 2022
Are GSK’s legal troubles a threat to the firm’s survival?
Biotech stocks

Are GSK’s legal troubles a threat to the firm’s survival?

Pharmaceutical giant GlaxoSmithKline is facing legal action over heartburn drug Zantac that has seen billions wiped off its market value. Rupert Hargr…
16 Aug 2022